Cystic Fibrosis Research Laboratory, Stanford University Stanford, California 94305-2130, USA
New evidence implicates salt-sensitive, natural antibiotics in lung mucosal defenses and may explain how a defective chloride channel leads to lung infections.
REFERENCES
di Sant'Agnese, P. et al. Sweat electrolyte disturbances associated with childhood pancreatic disease. Am. J. Med.15, 777−784 (1953). | Article | PubMed | ISI |
Zasloff, M., Magainins, a class of antimicrobial peptides from Xenopusskin: Isolation, characterization of two active forms, and partial cDNA sequence of a precursor. Proc. Natl. Acad. Sci. USA84, 5449−5453 (1987). | PubMed | ChemPort |
Bensch, K.W. et al. hBD-1: A novel beta-defensin from human plasma. FEBS Lett.368, 331−335 (1995). | Article | PubMed | ISI | ChemPort |
McCray, P.B. & Bentley, L. Human airway epithelia express a -defensin. Am. J. Respir. Cell Mol. Biol.16, 343−349 (1997). | PubMed | ISI | ChemPort |
Goldman, M.J. et al. Human -defensin-1 is a salt-sensitive antibiotic in lung that is inactivated in cystic fibrosis. Cell88, 553−560 (1997). | Article | PubMed | ISI | ChemPort |
Boucher, R.C. et al. Na+ transport in cystic fibrosis respiratory epithelia. Abnormal basal rate and response to adenylate cyclase activation. J. Clin. Invest.78, 1245−1252 (1986). | PubMed | ISI | ChemPort |
Engelhardt, J.F. et al. Submucosal glands are the predominant site of CFTR expression in the human bronchus. Nature Genet.2, 240−248 (1992). | PubMed | ISI | ChemPort |